No description available
No description available
Shares of Moderna (NASDAQ: MRNA) jumped 8.4% to a record closing high of $419.05 on Wednesday, as investors bid up the biotech's stock price ahead of its upcoming earnings announcement. Moderna said on Tuesday that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for its mRNA vaccine candidate against respiratory syncytial virus (RSV) in adults older than 60. The Fast Track designation will accelerate the FDA's review of Moderna's drug.
What happened Shares of BioNTech (NASDAQ: BNTX) had jumped 11.8% higher at 11:42 a.m. EDT on Wednesday. The gain came after The New York Times reported that the U.S. Food and Drug Administration will likely approve the Pfizer-BioNTech COVID-19 vaccine by early September.
There’s an old saying in the markets that you should ‘sell in May and go away.’ It’s a reference to long-noticed trend of summertime swoons, when market trading slows, or even dips, especially in August. Recent statistical research by CFRA research has quantified the phenomenon. Since 1945, they say, August is the year’s third-worst month for returns on the S&P 500, on average. The trend is particularly marked in years when the index set record high levels in July. A report from LPL Financial ad
Yahoo Finance's Jared Blikre joined Yahoo Finance Live to break down the key takeaways from Roku's recent earnings report.
Shares of Novavax (NASDAQ: NVAX) surged 18.7% on Wednesday after the biotechnology company struck a deal to supply as many as 200 million doses of its coronavirus vaccine candidate to the EU. Should Novavax's vaccine obtain regulatory approval, the European Commission (EC) will purchase up to 100 million doses. Novavax hopes to complete the rolling submission for its drug to the European Medicines Agency in the third quarter.
(Bloomberg) -- Bayer AG agreed to buy U.S. biotech company Vividion Therapeutics Inc. for as much as $2 billion, snapping up a developer of promising therapies that only weeks ago filed for an initial public offering.The German drugmaker will pay $1.5 billion up front and another $500 million in potential milestones for the San Diego-based biotech, it said in a statement Thursday. The company also raised its profit forecast for the year. For Bayer, the transaction is the latest in a string of de
In this article, we discuss the 10 stocks Reddit is piling into before earnings. If you want to skip our detailed analysis of these stocks, go directly to 5 Stocks Reddit is Piling Into Before Earnings. The stock market is on track to register a strong earnings quarter as more firms release their second quarter […]
Her performance in the Tokyo 2020 games had propelled her to new heights of popularity.
Shares of Zoom Video Communications (NASDAQ: ZM) were rising today on seemingly no company-related news. The maker of the popular video-calling app, Zoom, saw its share price jump today, likely because some investors are concerned that rising COVID-19 cases caused by the delta variant are bringing more restrictions. Zoom's app became the go-to service for communicating with friends, family, and colleagues during strict lockdowns and social distancing last year, and that helped drive up Zoom's share price in 2020.
Yahoo Finance's Ines Ferre joined Yahoo Finance Live to break down Etsy's latest earnings report.
Shares of BeyondSpring (NASDAQ: BYSI) soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung cancer treatment. A phase 3 trial of BeyondSpring's plinabulin treatment in combination with chemotherapy medication docetaxel to treat second and third line non-small cell lung cancer (NSCLC) reached its primary endpoint of statistically significant improvement in overall survival versus docetaxel alone. The combination treatment study also met its secondary endpoints, including significantly improving overall response rate (the proportion of patients whose tumor is reduced by a drug), progression-free survival rate, and 24- and 36-month overall survival rates.
In our second quarter, we managed through a significant outage that impacted our Q2 results and saw several customers delay their launch of new products, which will delay the timing of traffic coming on to our platform. Before we further discuss our strategy, I would like to discuss the outage and customer delays. The outage resulted from an undiscovered software bug that was triggered by a valid customer configuration change.
Yahoo Finance’s Jared Blikre reports on the day's trending tickers.
Shares of Alteryx (NYSE: AYX) were taking a dive today after the data analytics company once again offered up a disappointing earnings report. Alteryx beat estimates with its second-quarter earnings report.
Yahoo Finance’s Alexandra Canal to break down Rihanna’s path to becoming a billionaire and Jeff Bezos being dethroned as the world’s richest person.
Brian Sozzi gives us his take on Weber Grills ahead of the company’s IPO debut in the NYSE and also breaks down the features that differentiate Weber from other grill companies.
Roku and Etsy beat earnings, but sold off late. In a mixed market, AMD and Robinhood soared, signaling a meme stock shift.
(Bloomberg) -- Tesla Inc. Chairman Robyn Denholm sold 31,250 shares of the electric-vehicle maker for more than $22 million, according to a regulatory filing late Wednesday.Denholm, who recently testified in a Delaware court as part of a shareholder lawsuit over Tesla’s controversial 2016 acquisition of SolarCity, has served on Tesla’s board since August 2014.She became chair in November 2018 after Chief Executive Officer Elon Musk was forced to relinquish the role as part of his settlement agre
Shares of semiconductor manufacturer Nvidia (NASDAQ: NVDA) -- a supplier of chips for everything from playing video games to mining cryptocurrency to performing artificial intelligence tasks -- are posting a tidy 2.3% gain as of 2:25 p.m. EDT Wednesday. In a note out this morning, Rosenblatt raised its price target on Nvidia stock 25% to $250 -- that's incidentally about 25% above where the stock trades today. Rosenblatt cites Nvidia's earnings power on "best-in-class AI" and its opportunities in next generation networking and data processing as well as autonomous driving software, and apparently believes even the company's 94-times-earnings valuation currently is not too much to pay for Nvidia stock.
After a heady rally in the first half of 2021, Avis Budget Group (NASDAQ: CAR) stock suffered one of its worst declines so far this year on Wednesday, finishing the session down 16.6%. Avis Budget reported its best quarter in history on the evening of Aug. 3. From one of its worst-ever quarters this time last year to its best-ever quarter today, Avis Budget's turnaround is nothing short of remarkable.